Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pu Han

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Journal of Virology|September 15, 2025
Discovery of a potent covalent inhibitor that unusually distorts the catalytic dyad of SARS-CoV-2 main proteaseJuan Wang, Xiaohong Sang, Wenyan Zheng, et al.
Cell Reports|December 9, 2022
Cross-reaction of current available SARS-CoV-2 MAbs against the pangolin-origin coronavirus GX/P2V/2017Yunfei Jia, Sheng Niu, Yu Hu, et al.
Plos Pathogens|September 18, 2023
Broad protective RBD heterotrimer vaccines neutralize SARS-CoV-2 including Omicron sub-variants XBB/BQ.1.1/BF.7Yanfang Zhang, Xinrui Kang, Sheng Liu, et al.
EMBO Reports|June 16, 2026
Hemagglutinin double-mutation enhances binding of human-infecting avian influenza virus clade 2.3.4.4b H5Ny to human and SLe<sup>X</sup> receptorsXiyue Jin, Pu Han, Yuxuan Wang, et al.
Journal of Medical Virology|January 15, 2022
Aggregation of high-frequency RBD mutations of SARS-CoV-2 with three VOCs did not cause significant antigenic driftTao Li, Zhimin Cui, Yunfei Jia, et al.
Molecular Biomedicine|October 14, 2025
Development of a trispecific fusion protein based on angiotensin-converting enzyme 2, glycoprotein 130, and tumor necrosis factor receptor 2 as a promising therapeutic for COVID-19Yongfeng Qiao, Yanjun Han, Lu Zhao, et al.
Cell Discovery|July 12, 2022
Broader-species receptor binding and structural bases of Omicron SARS-CoV-2 to both mouse and palm-civet ACE2sLinjie Li, Pu Han, Baihan Huang, et al.
Cell|January 30, 2022
Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2Pengcheng Han, Linjie Li, Sheng Liu, et al.
Chinese Medical Journal|March 3, 2005
The protein X4 of severe acute respiratory syndrome-associated coronavirus is expressed on both virus-infected cells and lung tissue of severe acute respiratory syndrome patients and inhibits growth of Balb/c 3T3 cell lineYing-yu Chen, Bao Shuang, Ya-xia Tan, et al.
National Science Review|October 3, 2022
Cross-species recognition and molecular basis of SARS-CoV-2 and SARS-CoV binding to ACE2s of marine animalsShihua Li, Ruirui Yang, Di Zhang, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Journal of Virology|September 15, 2025
Discovery of a potent covalent inhibitor that unusually distorts the catalytic dyad of SARS-CoV-2 main proteaseJuan Wang, Xiaohong Sang, Wenyan Zheng, et al.
Cell Reports|December 9, 2022
Cross-reaction of current available SARS-CoV-2 MAbs against the pangolin-origin coronavirus GX/P2V/2017Yunfei Jia, Sheng Niu, Yu Hu, et al.
Plos Pathogens|September 18, 2023
Broad protective RBD heterotrimer vaccines neutralize SARS-CoV-2 including Omicron sub-variants XBB/BQ.1.1/BF.7Yanfang Zhang, Xinrui Kang, Sheng Liu, et al.
EMBO Reports|June 16, 2026
Hemagglutinin double-mutation enhances binding of human-infecting avian influenza virus clade 2.3.4.4b H5Ny to human and SLe<sup>X</sup> receptorsXiyue Jin, Pu Han, Yuxuan Wang, et al.
Journal of Medical Virology|January 15, 2022
Aggregation of high-frequency RBD mutations of SARS-CoV-2 with three VOCs did not cause significant antigenic driftTao Li, Zhimin Cui, Yunfei Jia, et al.
Molecular Biomedicine|October 14, 2025
Development of a trispecific fusion protein based on angiotensin-converting enzyme 2, glycoprotein 130, and tumor necrosis factor receptor 2 as a promising therapeutic for COVID-19Yongfeng Qiao, Yanjun Han, Lu Zhao, et al.
Cell Discovery|July 12, 2022
Broader-species receptor binding and structural bases of Omicron SARS-CoV-2 to both mouse and palm-civet ACE2sLinjie Li, Pu Han, Baihan Huang, et al.
Cell|January 30, 2022
Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2Pengcheng Han, Linjie Li, Sheng Liu, et al.
Chinese Medical Journal|March 3, 2005
The protein X4 of severe acute respiratory syndrome-associated coronavirus is expressed on both virus-infected cells and lung tissue of severe acute respiratory syndrome patients and inhibits growth of Balb/c 3T3 cell lineYing-yu Chen, Bao Shuang, Ya-xia Tan, et al.
National Science Review|October 3, 2022
Cross-species recognition and molecular basis of SARS-CoV-2 and SARS-CoV binding to ACE2s of marine animalsShihua Li, Ruirui Yang, Di Zhang, et al.
Pageof 10